Dose calculator

Liraglutide dose calculator

Convert any Liraglutide dose into syringe units in real time, pre-filled with a 6 mg / 3 mL example.

iPhone · Free to download

Last updated: May 13, 2026

Vial (mg)

Diluent (mL)

Dose (mg)

Dose unit

Draw on a U-100 syringe

60.0 units

Volume to draw

0.600 mL

Liraglutide is a modified version of a hormone your gut naturally produces called GLP-1, which is involved in appetite and blood sugar. People use it to support weight management and help regulate blood sugar levels, often in conjunction with diet and exercise. Studies, such as the SCALE trial, reported that participants using Liraglutide saw a greater reduction in body weight compared to a placebo group. This page explains what Liraglutide is, how people use it, and how to track a daily dosing protocol in the Peptide Pilot app.

How the Liraglutide dose calculator works

Liraglutide is the daily GLP-1 — same mechanism as semaglutide, but a much shorter half-life means a dose every day instead of once a week. A 6 mg vial mixed with 3 mL gives 2 mg/mL, so a 1.2 mg daily dose draws 60 units. The calculator handles each daily titration step.

The formula is volume in mL equals dose mg divided by concentration mg/mL, then volume times one hundred to get units on a U-100 insulin syringe. With a 2 mg/mL Liraglutide solution and a 1.2 mg dose, the draw is 0.60 mL or about 60 units. Type any other dose and the unit count updates in real time — no spreadsheets, no guesswork.

Inputs that genuinely matter: concentration (which only changes when you reconstitute a new vial) and dose mass. Syringe type matters too, but only because U-100 vs U-40 changes the multiplier — almost every modern insulin syringe is U-100, which is why the math defaults to that. Edge cases worth flagging: switching from mcg to mg without checking the input unit, or carrying yesterday's unit count over to a new vial that was reconstituted with a different volume of BAC water.

Figuring out the right dose is a core part of any peptide protocol, and with a daily peptide like Liraglutide, precision is key. This calculator is designed to make that process simple and repeatable. You just need to input the details of your specific vial—the total milligrams of peptide powder and the amount of diluent you added. Once the calculator knows your concentration, you just enter your desired dose in milligrams, and it will tell you the exact volume to draw into your syringe. This is especially helpful during titration, when your daily dose is changing from week to week. Instead of doing the math from scratch every time you adjust your dose, you can just plug in the new number.

This tool removes the potential for human error in your calculations, giving you confidence that you’re administering the amount you intend to. Whether your protocol calls for 0.6 mg, 1.2 mg, or any other specific dose, the calculator provides a quick and accurate answer in both milliliters (mL) and the corresponding units on an insulin syringe. This immediate conversion is helpful because while doses are planned in milligrams, they are administered in units. Using this calculator as part of your daily routine helps ensure consistency and accuracy in your tracking, which are fundamental to a well-managed peptide journey. It’s a simple step that supports the overall integrity of your protocol.

Think of this calculator as your daily dose-checking assistant. It helps you confirm your math before every single injection, which is particularly useful for a peptide administered as frequently as Liraglutide. The process is straightforward: you tell the calculator about your unique vial, and it handles the conversion from the desired milligram dose to the correct volume for injection. This ensures every dose aligns with your protocol’s titration schedule, from the first day at a low dose to the final maintenance dose. By making this calculation effortless, the tool lets you focus more on tracking how you feel and less on the arithmetic. It helps build a strong foundation of accurate data logging within the Peptide Pilot app.

Worked example

Walking one Liraglutide dose through the math

The vial holds 6 mg of Liraglutide, mixed into 3 mL of bacteriostatic water — concentration 2.00 mg/mL.
Your 1.2 mg dose ÷ 2.00 mg/mL = 0.600 mL of solution to pull.
Multiply by 100 (because U-100 means 100 units per mL): 0.600 × 100 = 60 units.
Double the dose to 2.4 mg and the unit count doubles to 120 — the relationship is linear at a fixed concentration.
Change the diluent volume and every one of these numbers moves; change the dose alone and only the last one does.

Liraglutide titration ladder at this concentration

What different Liraglutide dose steps draw on a U-100 insulin syringe at the example 2.00 mg/mL concentration.

Dose (mg)	Volume (mL)	Units (U-100)
0.6	0.300	30
1.2	0.600	60
2.4	1.200	120
4.8	2.400	240

Doubling the Liraglutide dose doubles the unit count. Halving it halves the count. Step-ups under 5 units are hard to read accurately — re-reconstitute with more water if your titration hits that range.

Scenarios people actually run into

Three things that come up logging Liraglutide

You're sitting at the 1.2 mg Liraglutide step and your prescriber bumps you up. The new dose is double — 120 units instead of 60. Same vial, same syringe, twice the volume on the line.
Your fingers reach for the syringe and the unit count from last week is still in your head. Half the time that number is fine; the other half, the vial changed and the right answer moved. The calculator is the second pair of eyes.
You skipped a week. Liraglutide cadence is 7 doses per week, and doubling up to "catch up" almost never reads how people expect — log the skip, then log the next normal dose.

Same-category neighbor

Liraglutide next to Tirzepatide

Both sit in the GLP-1 bucket — here's the dose math side by side on each one's example vial.

	Liraglutide	Tirzepatide
Example dose	1.2 mg	2.5 mg
Concentration	2.00 mg/mL	5.00 mg/mL
Units to draw	60	50

Want the full breakdown? Tirzepatide reference →

How Liraglutide dosing is tracked

A typical Liraglutide protocol is built around a daily injection schedule and a slow, steady dose increase. The goal of this titration is to let your body get used to the peptide, which helps manage potential side effects, particularly nausea. Most people start with a low dose, commonly 0.6 mg, injected once per day. This starting dose is usually maintained for at least one week. If the person feels comfortable and side effects are minimal, they might increase the daily dose for the following week. The titration schedule is often linear. For example, a common path is to increase the daily dose by 0.6 mg each week: 0.6 mg daily in week one, 1.2 mg daily in week two, 1.8 mg daily in week three, 2.4 mg daily in week four, and finally reaching the common target dose of 3.0 mg daily in week five. This gradual ramp-up is a cornerstone of how Liraglutide is used.

Once the target dose is reached, the protocol shifts to a maintenance phase. For many, this means continuing with the same daily dose, for example, 3.0 mg, for the duration of their tracking period. Consistency is important, so users generally inject it at the same time each day to help maintain stable levels in the bloodstream and establish a routine. Some people might find that a lower dose is effective for them, and they may choose to stay at 1.8 mg or 2.4 mg daily instead of proceeding to the maximum dose. This decision is often based on a balance between the desired effects (appetite suppression, blood sugar stability) and managing any persistent side effects. The Peptide Pilot app is a great place to log these decisions and track not just the dose but also the subjective feelings and outcomes that inform the protocol.

Unlike some peptides that are cycled (used for a period, then stopped for a break), Liraglutide is often used continuously for extended periods, sometimes many months or longer, especially when tied to weight management goals. There isn’t a standard “off-cycle” period defined in research protocols. The duration is highly individual. Some users may continue the protocol as long as they find it beneficial and manageable. It’s also important to rotate injection sites. Repeatedly injecting into the same small spot can cause skin irritation or changes in the fatty tissue under the skin, called lipohypertrophy, which can affect absorption. Common injection sites include the abdomen, thigh, or upper arm. Tracking these sites in Peptide Pilot can help ensure you’re moving the injection spot around consistently.

If a person decides to stop, the approach can vary. Some may simply stop the daily injections, especially if they are on a lower dose. Others, particularly those on a higher maintenance dose, might choose to titrate down. This would involve reversing the initial titration schedule, stepping down the dose week by week. For example, someone on 3.0 mg daily might decrease to 2.4 mg for a week, then 1.8 mg, and so on. The idea is to gently wean the body off the peptide, though stopping abruptly is also common. The experience of discontinuing Liraglutide is individual. Some report a gradual return of appetite to their pre-peptide baseline. Logging these experiences provides valuable personal data for future reference and understanding how your body responds to the peptide from start to finish.

Common Liraglutide dose-calculation mistakes

Failing to titrate the dose up slowly.
Assuming all GLP-1 agonists have the same daily dosing schedule.
Miscalculating the dose when reconstituting a vial.

Frequently asked questions about Liraglutide dose calculator

How does the Liraglutide dose calculator turn mg into syringe units?

It runs two divisions in sequence. First it computes concentration (vial mg ÷ diluent mL) — for the example here that's 6 ÷ 3 = 2.00 mg/mL. Then it divides your dose by that concentration to get volume in mL, and multiplies by 100 to convert volume into U-100 syringe units. The output updates as you type so you can sanity-check before drawing. Liraglutide titration in the SCALE trial stepped weekly, not monthly — daily logging makes the up-step easy to spot.

Does the Liraglutide dose calculator know which syringe I'm using?

It assumes a U-100 insulin syringe — the most common type for sub-cutaneous peptide injections. U-100 means 100 units per mL. If you're using a U-40 syringe (rare outside veterinary contexts) the unit count is wrong by a factor of 2.5. Tuberculin syringes read in mL directly, so on those just use the volume figure. Liraglutide titration in the SCALE trial stepped weekly, not monthly — daily logging makes the up-step easy to spot.

Why does the same Liraglutide dose pull a different unit count today than last week?

Because either the vial or the diluent volume changed. Concentration depends on both. A 5 mg vial reconstituted with 1 mL is twice as concentrated as the same vial with 2 mL — same dose, half the units. Whenever you open a fresh vial, run the dose math again rather than carrying the prior count over. Liraglutide titration in the SCALE trial stepped weekly, not monthly — daily logging makes the up-step easy to spot.

What if my Liraglutide dose lands at fewer than 5 units?

That's the calculator telling you the current vial is too concentrated for the dose you want. Five units on a U-100 syringe is hard to read accurately — the markings get tight. Reconstitute the next vial with more bacteriostatic water (commonly 2 mL instead of 1 mL) so each dose covers a larger, cleaner volume. Liraglutide titration in the SCALE trial stepped weekly, not monthly — daily logging makes the up-step easy to spot.

Related on Peptide Pilot

Log every Liraglutide dose in the app

iPhone · Free · No credit card